ExploreWatchlistsPricing
  1. JP-listed companies
  2. Kubota Pharmaceutical Holdings Co., Ltd.
  3. Financials
  4. Cash from operations

Kubota Pharmaceutical Holdings Co., Ltd. (4596)

Market cap
¥11.2B
P/E ratio
Kubota Pharmaceutical develops innovative eye disease treatments including wearable myopia devices and pharmaceuticals for conditions like diabetic retinopathy.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Dec 31, 2025-583-51.22%
Dec 31, 2024-1,195-10.54%
Dec 31, 2023-1,336-35.98%
Dec 31, 2022-2,087-16.98%
Dec 31, 2021-2,514+11.78%
Dec 31, 2020-2,249-34.22%
Dec 31, 2019-3,418+33.36%
Dec 31, 2018-2,563-22.58%
Dec 31, 2017-3,311+4.96%
Dec 31, 2016-3,154

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat